Radiopharm Theranostics Limited(AU:RAD)
A$0.010.00 (0.00%)
AU:RAD
Radiopharm Theranostics Limited financials statements
A$0.01
At close:0.00 (0.00%)
Want to see AU:RAD full AI Analyst Report?
Radiopharm Theranostics Limited (RAD) Ratios
25 Followers
Radiopharm Theranostics Limited Ratios
AU:RAD's free cash flow for Q4 2026 was AU$0.00. For the 2026 fiscal year, AU:RAD's free cash flow was increased by AU$30.11M and operating cash flow was AU$-30.11M. See a summary of the company’s cash flow.
| Ratios | Jun 26 | Jun 25 | Jun 24 | Jun 23 | Jun 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.16 | 2.67 | 1.30 | 1.23 | 3.46 |
| Quick Ratio | 1.16 | 2.67 | 1.30 | 1.23 | 3.46 |
| Cash Ratio | 0.22 | 1.95 | 1.06 | 0.88 | 3.42 |
| Solvency Ratio | -1.46 | -0.78 | -1.00 | -1.07 | -1.34 |
| Operating Cash Flow Ratio | -2.79 | -2.45 | -1.31 | -1.75 | -1.26 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | AU$ -15.88M | AU$ -3.76M | AU$ -21.83M | AU$ -13.07M | AU$ 6.85M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-Equity Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 2.44 | 1.93 | 2.56 | 1.69 | 1.32 |
| Debt Service Coverage Ratio | -607.38 | -486.22 | -70.73 | -431.47 | -1.93 |
| Interest Coverage Ratio | -607.93 | -584.59 | -73.43 | -468.02 | -2.13 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.03 |
| Net Debt to EBITDA | 0.06 | 0.92 | 0.41 | 0.32 | 1.50 |
| Profitability Margins | |||||
| Gross Profit Margin | -77.67% | 73.18% | -7121.04% | -1027.56% | -33661.57% |
| EBIT Margin | -2468.61% | -255.53% | -16209.19% | -13820.19% | -237174.08% |
| EBITDA Margin | -2468.35% | -236.16% | -15164.41% | -12692.63% | -204330.06% |
| Operating Profit Margin | -2468.61% | -284.87% | -15777.22% | -13781.81% | -225527.71% |
| Pretax Profit Margin | -2055.58% | -285.36% | -15992.07% | -13849.64% | -343048.15% |
| Net Profit Margin | -1992.46% | -273.90% | -16024.28% | -11838.59% | -343550.89% |
| Continuous Operations Profit Margin | -2053.61% | -286.13% | -16024.28% | -11838.59% | -343550.89% |
| Net Income Per EBT | 96.93% | 95.98% | 100.20% | 85.48% | 100.15% |
| EBT Per EBIT | 83.27% | 100.17% | 101.36% | 100.49% | 152.11% |
| Return on Assets (ROA) | -91.71% | -42.44% | -66.56% | -46.18% | -36.39% |
| Return on Equity (ROE) | -223.39% | -81.94% | -170.50% | -77.98% | -48.19% |
| Return on Capital Employed (ROCE) | -165.70% | -53.35% | -86.69% | -65.28% | -26.38% |
| Return on Invested Capital (ROIC) | -165.54% | -53.35% | -86.69% | -65.28% | -26.38% |
| Return on Tangible Assets | -251.00% | -91.97% | -208.94% | -210.94% | -111.11% |
| Earnings Yield | -81.90% | -80.00% | -326.51% | -114.12% | -81.05% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.16 | 1.29 | 0.30 | 0.07 | 0.16 |
| Payables Turnover | 0.90 | 0.57 | 3.36 | 1.12 | 2.51 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 59.99 | 250.63 | 4.92 | 4.28 | 5.60 |
| Asset Turnover | 0.05 | 0.15 | 0.00 | 0.00 | 0.00 |
| Working Capital Turnover Ratio | 0.20 | 0.89 | 0.07 | 0.03 | 0.00 |
| Cash Conversion Cycle | 1895.06 | -361.33 | 1095.76 | 5250.67 | 2188.86 |
| Days of Sales Outstanding | 2300.78 | 283.28 | 1204.45 | 5578.03 | 2334.50 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 405.72 | 644.60 | 108.69 | 327.35 | 145.64 |
| Operating Cycle | 2300.78 | 283.28 | 1204.45 | 5578.03 | 2334.50 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.01 | -0.02 | -0.06 | -0.07 | -0.04 |
| Free Cash Flow Per Share | 0.00 | -0.02 | -0.06 | -0.08 | -0.14 |
| Dividend Paid and CapEx Coverage Ratio | -1.00 | 0.00 | -4595187.00 | -15.16 | -0.35 |
| Capital Expenditure Coverage Ratio | -1.00 | 0.00 | -4595187.00 | -15.16 | -0.35 |
| Operating Cash Flow Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Cash Flow to Sales Ratio | -19.07 | -2.73 | -76.78 | -79.36 | -1121.82 |
| Free Cash Flow Yield | 0.00% | -79.87% | -156.45% | -81.55% | -102.17% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -1.22 | -1.25 | -0.31 | -0.88 | -1.23 |
| Price-to-Sales (P/S) Ratio | 24.33 | 3.42 | 49.08 | 103.74 | 4238.84 |
| Price-to-Book (P/B) Ratio | 2.73 | 1.02 | 0.52 | 0.68 | 0.59 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 0.00 | -1.25 | -0.64 | -1.23 | -0.98 |
| Price-to-Operating Cash Flow Ratio | -1.28 | -1.25 | -0.64 | -1.31 | -3.78 |
| Price-to-Earnings Growth (PEG) Ratio | 0.11 | 0.01 | -0.03 | 0.00 | -0.00 |
| Enterprise Value Multiple | -0.93 | -0.53 | 0.09 | -0.50 | -0.58 |
| Enterprise Value | 63.20M | 16.76M | -3.89M | 18.63M | 10.45M |
| EV to EBITDA | -0.93 | -0.53 | 0.09 | -0.50 | -0.58 |
| EV to Sales | 22.83 | 1.25 | -13.00 | 63.72 | 1183.79 |
| EV to Free Cash Flow | 0.00 | -0.46 | 0.17 | -0.75 | -0.27 |
| EV to Operating Cash Flow | -1.20 | -0.46 | 0.17 | -0.80 | -1.06 |
| Tangible Book Value Per Share | -0.00 | -0.00 | -0.06 | -0.04 | 0.02 |
| Shareholders’ Equity Per Share | 0.01 | 0.02 | 0.07 | 0.14 | 0.23 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| Revenue Per Share | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | -0.02 | -0.02 | -0.12 | -0.11 | -0.11 |
| Tax Burden | 0.97 | 0.96 | 1.00 | 0.85 | 1.00 |
| Interest Burden | 0.83 | 1.12 | 0.99 | 1.00 | 1.45 |
| Research & Development to Revenue | 18.05 | 2.05 | 58.68 | 75.34 | 847.77 |
| SG&A to Revenue | 5.86 | 1.23 | 43.58 | 44.54 | 1408.51 |
| Stock-Based Compensation to Revenue | 0.00 | 0.14 | 8.82 | 10.39 | 543.62 |
| Income Quality | 0.96 | 1.00 | 0.48 | 0.67 | 0.33 |
Currency in AUD

